Document is current
Any future updates will be listed below
-
Authors
Le Goff, Marie https://orcid.org/0009-0001-9991-8369
Zaarour, Youssef
Melica, Giovanna
Bay, Pierre
Fourati, Slim
de Prost, Nicolas
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 25 November 2025
First Online: 8 December 2025
Declarations
:
: Slim Fourati has served as a speaker for GlaxoSmithKline, AstraZeneca, MSD, Pfizer, Cepheid and Moderna; Nicolas De Prost has served as an advisor or speaker for Moderna, CEMKA, and AstraZeneca; Marie Le Goff, Youssef Zaarour, Giovana Melica, and Pierre Bay have nothing to disclose.
: This study received ethical approval from the Ethics Committee of the Société de Réanimation de Langue Française (SRLF): reference CE SRLF 25-019. In accordance with French regulations, this retrospective study, which was based on routinely collected data, was conducted under the legal framework of “non-opposition” to research use. Patients or their representatives were informed through the hospital’s standard procedures for providing information, including the department’s public registry of ongoing research projects, which is available online at , and the patient information guide provided upon admission.
